Education
About Us
Working with TipRanks
Follow Us
ADAR1 Capital Management, LLC Insider Profile
4 Followers
ADAR1 Capital Management, LLC, Ten Percent Owner at Palvella Therapeutics, holds 5.13M shares in Keros Therapeutics (Ticker: KROS), holds 144.64K shares in Palvella Therapeutics (Ticker: PVLA). Most recently, ADAR1 Capital Management, LLC Sold ― shares of Keros Therapeutics on Jun 24, 2025 for an estimated value of 118.00K.
ADAR1 Capital Management, LLC Palvella Therapeutics (PVLA)Ten Percent Owner
Palvella Therapeutics (PVLA)
Ten Percent Owner
Ranked #26,679 out of 102,474 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+22.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that ADAR1 Capital Management, LLC holds in companies
Most Profitable Insider Trade
The most profitable trade made by ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC's Trading History
Palvella Therapeutics
Aug 12, 2024
Ten Percent Owner
Informative Buy
92.31K
$3.49M
Keros Therapeutics
Jun 24, 2025
Ten Percent Owner
Informative Sell
118.00K
$69.06M
List of latest transactions for each holding click on a transaction to see ADAR1 Capital Management, LLC's performance on stock
You May Also Like
ADAR1 Capital Management, LLC insider profile FAQ
What is the percentage of profitable transactions made by ADAR1 Capital Management, LLC?
The percentage of profitable transactions made by ADAR1 Capital Management, LLC is 100%.
What is the average return per transaction made by ADAR1 Capital Management, LLC?
The average return per transaction made by ADAR1 Capital Management, LLC is 22.00%.
What stocks does ADAR1 Capital Management, LLC hold?
ADAR1 Capital Management, LLC holds: PVLA, KROS stocks.
What was ADAR1 Capital Management, LLC’s latest transaction?
ADAR1 Capital Management, LLC latest transaction was an Informative Sell of $118.00K.
What was ADAR1 Capital Management, LLC's most profitable transaction?
ADAR1 Capital Management, LLC’s most profitable transaction was an Informative Buy of PVLA stock on August 12, 2024. The return on the trade was 51.70%.
What is ADAR1 Capital Management, LLC's role in Palvella Therapeutics?
ADAR1 Capital Management, LLC's role in Palvella Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.